Affordable Access

deepdyve-link
Publisher Website

Esophageal cancer stem cells express PLGF to increase cancer invasion through MMP9 activation.

Authors
  • Chen, Yue
  • Jiang, Tinghui
  • Mao, Aiwu
  • Xu, Jianrong
Type
Published Article
Journal
Tumor Biology
Publisher
SAGE Publications
Publication Date
Dec 01, 2014
Volume
35
Issue
12
Pages
12749–12755
Identifiers
DOI: 10.1007/s13277-014-2601-x
PMID: 25213700
Source
Medline
License
Unknown

Abstract

Cancer stem cells (CSCs) are a distinct population in tumors and cause cancer relapse and metastasis. Thus, treating CSCs are believed to be potential to cure rapidly growing and highly metastatic cancers. To date, CSCs in esophageal cancer have not been characterized. In the current study, we detected significant higher levels of placental growth factor (PLGF) and matrix metalloproteinase 9 (MMP9) in the esophageal cancers with metastasis, compared to those without metastasis, in which the expression levels of PLGF and MMP9 strongly correlated with each other. Thus, we used a human esophageal cancer cell line, TE-1, to examine the cross talk of PLGF and MMP9. We found that the levels of PLGF in TE-1 cells positively affected the levels of MMP9, while the levels of MMP9 did not affected the levels of PLGF, suggesting that PLGF may activate MMP9 in esophageal cancer cells. Then, we separated PLGF-positive and PLGF-negative TE-1 cells that had been transfected with a GFP reporter under a PLGF promoter by flow cytometry. We found that PLGF-positive cells grew significantly faster than PLGF-negative cells both in vitro and in vivo in a stereotactical implantation model, suggesting that PLGF-positive cells are likely CSCs in esophageal cancer. Taken together, we demonstrate that PLGF-positive cells appear to be CSCs in esophageal cancer, and they may release PLGF to promote cancer metastasis through MMP9 activation.

Report this publication

Statistics

Seen <100 times